EMD-66671

Single-particle
3.45 Å
EMD-66671 Deposition: 21/10/2025
Map released: 02/09/2026
Last modified: 02/09/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-66671

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9x9t summary report (pdf.gz) Map-9x9t FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Local refinement of SARS-CoV-2 KP.3.1.1 RBD with BD57-2704 and AB2-122 Fab

EMD-66671

Single-particle
3.45 Å
EMD-66671 Deposition: 21/10/2025
Map released: 02/09/2026
Last modified: 02/09/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: BD57-2704_AB2-122_KP.3.1.1 RBD
Fitted models: 9x9t

Deposition Authors: Cao YL, Wang YX
Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models.
PUBMED: 41871249
DOI: doi:10.1073/pnas.2537053123
ISSN: 1091-6490
ASTM: PNASA6
Grant Support: